Facebook Pixel Code
SBoCK Banner image
Simple Bone Cyst in Kids

Protection for Subjects

We would like to take this opportunity to reassure patients that all clinical trial subjects are treated in a safe, respectful, and honest manner. In fact, there are many regulations and guidelines in place to protect subjects from harm. Research activities are closely monitored by groups who are independent of the trials to check that they are following all applicable rules.

One of these independent groups is the research ethics board (REB) or institutional review board (IRB). All research conducted in human subjects must be approved by the REB or IRB. Members on the board are professionals from various backgrounds. They meet regularly to review applications submitted by research teams to start, change, continue, or end clinical trials. REBs or IRBs can approve or reject any application they receive. They also have the power to temporarily or permanently stop trials if they have any concerns.

If you have additional questions, please contact your local REB or IRB. Their contact information is usually listed on your informed consent form.